NCT00324480View on ClinicalTrials.gov

Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

April 30, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

alvocidib

Given IV

DRUG

vorinostat

Given orally

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00324480 - Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter